MetaADEDB 2.0 @ LMMD
propoxyphene napsylate
(VZPXFHVJUUSVLH-MYXGOWFTSA-N)
Structure
SMILES
OS(=O)(=O)c1ccc2c(c1)cccc2.CCC(=O)O[C@](c1ccccc1)([C@@H](CN(C)C)C)Cc1ccccc1
Molecular Formula:
C32H37NO5S
Molecular Weight:
547.705
Log P:
7.4428
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
1
TPSA:
92.29
CAS Number(s):
17140-78-2
Synonym(s)
1.
propoxyphene napsylate
2.
d-propoxyphene napsylate
3.
dextropropoxyphene napsylate
External Link(s)
MeSHC084813
PubChem Compound28332
Therapeutic Target DatabaseD0HF0W
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Chest PainFAERS: 1US FAERS
2DysuriaFAERS: 1US FAERS
3HypersensitivityFAERS: 1US FAERS
4PruritusFAERS: 1
Canada Vigilance: 6
Canada Vigilance
US FAERS
5Abdominal PainCanada Vigilance: 5Canada Vigilance
OFFSIDES
6Abdominal discomfortOFFSIDES
7Accidental overdoseCanada Vigilance: 1Canada Vigilance
8AcidosisOFFSIDES
9AcneCanada Vigilance: 1Canada Vigilance
10Acute respiratory failureOFFSIDES
11AdenitisOFFSIDES
12Adnexa uteri massOFFSIDES
13Alcohol abuseOFFSIDES
14AmphetaminesOFFSIDES
15AnhedoniaOFFSIDES
16AnorexiaOFFSIDES
17AnxietyCanada Vigilance: 1Canada Vigilance
OFFSIDES
18ApathyOFFSIDES
19Arteriogram coronary abnormalOFFSIDES
20AsphyxiaCanada Vigilance: 1Canada Vigilance
21AstheniaCanada Vigilance: 1Canada Vigilance
OFFSIDES
22AtelectasisOFFSIDES
23Bipolar DisorderOFFSIDES
24Blood alkaline phosphatase increasedCanada Vigilance: 1Canada Vigilance
25Blood cholesterolOFFSIDES
26Blood uric acidOFFSIDES
27Bone density decreasedOFFSIDES
28Borderline Personality DisorderOFFSIDES
29Bowel movement irregularityOFFSIDES
30BradycardiaOFFSIDES
31CalcinosisOFFSIDES
32CellulitisOFFSIDES
33Cerebellar infarctionOFFSIDES
34Choking sensationOFFSIDES
35Cholecystitis infectiveOFFSIDES
36ChromaturiaCanada Vigilance: 1Canada Vigilance
37Chronic Obstructive Airway DiseaseOFFSIDES
38Chronic sinusitisOFFSIDES
39Completed SuicideCanada Vigilance: 10Canada Vigilance
40ConfabulationOFFSIDES
41ConstipationCanada Vigilance: 4Canada Vigilance
42Contact DermatitisOFFSIDES
43Conversion disorderCanada Vigilance: 1Canada Vigilance
44DehydrationOFFSIDES
45DemyelinationOFFSIDES
46Denture wearerOFFSIDES
47DependenceOFFSIDES
48Dependent Personality DisorderOFFSIDES
49DermatitisCanada Vigilance: 1Canada Vigilance
50DiarrheaOFFSIDES
51DiplopiaCanada Vigilance: 2Canada Vigilance
OFFSIDES
52DisorientationCanada Vigilance: 1Canada Vigilance
53DiverticulumOFFSIDES
54DizzinessCanada Vigilance: 10Canada Vigilance
55Drug withdrawal convulsionsCanada Vigilance: 1Canada Vigilance
56DysmenorrheaOFFSIDES
57DyspepsiaCanada Vigilance: 1Canada Vigilance
58DysphoniaOFFSIDES
59Economic problemOFFSIDES
60EczemaOFFSIDES
61Embolic strokeOFFSIDES
62EmbolismOFFSIDES
63Emotional distressOFFSIDES
64EndocarditisOFFSIDES
65EpistaxisCanada Vigilance: 1Canada Vigilance
66Erythema MultiformeCanada Vigilance: 1Canada Vigilance
67ErythemaCanada Vigilance: 3Canada Vigilance
68Eustachian tube disorderOFFSIDES
69Eye painOFFSIDES
70Face LiftOFFSIDES
71Fatty LiverOFFSIDES
72Fixed eruptionCanada Vigilance: 1Canada Vigilance
73GastritisCanada Vigilance: 1Canada Vigilance
74Gingival HyperplasiaOFFSIDES
75GlossitisCanada Vigilance: 1Canada Vigilance
76GoiterOFFSIDES
77HeadacheCanada Vigilance: 3Canada Vigilance
78HepatitisCanada Vigilance: 3Canada Vigilance
79HypophagiaOFFSIDES
80Ileal ulcerOFFSIDES
81ImpetigoOFFSIDES
82InflammationCanada Vigilance: 1Canada Vigilance
83Intellectual DisabilityCanada Vigilance: 1Canada Vigilance
84Intention tremorOFFSIDES
85Joint injuryOFFSIDES
86Keratitis siccaOFFSIDES
87Kidney FailureOFFSIDES
88Kidney Papillary Necrosis6126946CTD
89Life expectancy shortenedOFFSIDES
90MalaiseCanada Vigilance: 2Canada Vigilance
91Medical device removalOFFSIDES
92Medication ErrorCanada Vigilance: 1Canada Vigilance
93Metabolic acidosisOFFSIDES
94Multiple MyelomaOFFSIDES
95Multiple drug overdoseOFFSIDES
96Musculoskeletal PainOFFSIDES
97Nail InfectionOFFSIDES
98NauseaCanada Vigilance: 10Canada Vigilance
OFFSIDES
99Nephrocalcinosis6126946CTD
100NephrolithiasisOFFSIDES
101NoduleOFFSIDES
102Oropharyngeal painOFFSIDES
103Oropharyngeal plaqueOFFSIDES
104OsteolysisOFFSIDES
105OsteomyelitisOFFSIDES
106OsteopeniaOFFSIDES
107PainOFFSIDES
108PallorCanada Vigilance: 1Canada Vigilance
109PalpitationsCanada Vigilance: 1Canada Vigilance
110PancreatitisOFFSIDES
111ParotitisOFFSIDES
112Physical disabilityOFFSIDES
113PneumothoraxOFFSIDES
114Pulmonary HypertensionOFFSIDES
115Rash erythematousCanada Vigilance: 2Canada Vigilance
116Renal tubular necrosisOFFSIDES
117Respiratory FailureOFFSIDES
118Restrictive pulmonary diseaseOFFSIDES
119Retinal VasculitisOFFSIDES
120RhinitisCanada Vigilance: 1Canada Vigilance
121SarcoidosisOFFSIDES
122Septic ShockOFFSIDES
123SinusitisOFFSIDES
124Sjogren's SyndromeOFFSIDES
125SomnolenceCanada Vigilance: 1Canada Vigilance
126Synovial CystOFFSIDES
127Thermal burnCanada Vigilance: 1Canada Vigilance
128TinnitusCanada Vigilance: 2Canada Vigilance
129Tooth ExtractionOFFSIDES
130Unresponsive to stimuliOFFSIDES
131UrticariaCanada Vigilance: 9Canada Vigilance
132Uterine PolypOFFSIDES
133VertigoCanada Vigilance: 2Canada Vigilance
134Visual ImpairmentCanada Vigilance: 1Canada Vigilance
135VomitingCanada Vigilance: 8Canada Vigilance
136Wound dehiscenceOFFSIDES
137jaundiceCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.